SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 237 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $724,596 | +3.7% | 24,105 | +6.2% | 0.00% | 0.0% |
| Q2 2021 | $699,000 | -28.8% | 22,690 | -39.5% | 0.00% | -25.0% |
| Q1 2021 | $982,000 | +87.0% | 37,510 | +79.6% | 0.00% | +100.0% |
| Q4 2020 | $525,000 | +101.9% | 20,880 | +90.6% | 0.00% | +100.0% |
| Q2 2020 | $260,000 | +39.8% | 10,956 | +6.2% | 0.00% | 0.0% |
| Q1 2020 | $186,000 | -52.7% | 10,321 | -37.7% | 0.00% | -50.0% |
| Q4 2019 | $393,000 | -13.8% | 16,576 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $456,000 | -16.8% | 16,576 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $548,000 | -48.4% | 16,576 | -21.4% | 0.00% | -50.0% |
| Q3 2018 | $1,062,000 | -14.4% | 21,091 | +1.8% | 0.01% | -14.3% |
| Q2 2018 | $1,240,000 | +0.3% | 20,711 | -23.3% | 0.01% | 0.0% |
| Q1 2018 | $1,236,000 | +15.4% | 26,991 | +0.5% | 0.01% | +16.7% |
| Q4 2017 | $1,071,000 | +105.2% | 26,866 | +105.7% | 0.01% | +100.0% |
| Q3 2017 | $522,000 | – | 13,061 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |